Pfizer’s COVID-19 vaccine candidate shown to be 90% effective

11-09-20

BNT162b2 is shown to prevent more than 90% of infections with the virus that causes COVID-19.

94 trial participants to come down with COVID-19, the vaccine was found to be more than 90% effective in preventing the disease.

There were no serious safety concerns reported to the independent data monitoring board that reviews both safety and effectiveness data for this testing.

Leave a Reply

Your email address will not be published. Required fields are marked *